Postmastectomy radiation and survival in patients with breast cancer

Journal of Cancer Research and Therapeutics

Volumn 3, Issue 4, 2007, Pages 218-224

  Yadav, B S ^a   Sharma, S C ^a   Singh, R ^a   Singh, G ^a   Kumar, V ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Breast cancer; Postmastectomy radiation therapy; Prognostic factors

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGE; ARTICLE; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POSTOPERATIVE CARE; UNIVARIATE ANALYSIS;

EID: 39349101984     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.38997     Document Type: Article

References (20)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 1995;333:1444-55.
2. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994;12:447-53.
3. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55.
4. Ragaz J, Jackson S, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
5. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-8.
6. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long term survival for radiotherapy for early breast cancer: An overview of the randomized trials. Lancet 2000;355:1757-70.
7. Ribiero GG, Magee B, Swindell R, Harris M, Banerjee SS. The Christie hospital breast conservation trial: An update at 8 years from inception. Clin Oncol (R Coll Radiol) 1993;5:278-83.
8. Fowble BL, Schultz DJ, Overmoyer B, Solin LJ, Fox K, Jardines L, et al. The influence of young age on outcome in early breast cancer. Int J Radiat Oncol Biol Phys 1994;30:23-33.
9. Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, et al. Clinical investigation: Regional nodal failure patterns in breast cancer paients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:1508-13.
10. Fisher BJ, Prera FE, Cook AL, Opeitum A, Dar AR, Venkatesan VM, et al. Extracapsular axillary node extension in patients recieving adjuant systemic therapy: An indication for radiotherapy? Int J Radiat Oncol Biol Phys 1997;38:551-9.
11. Leonard C, Corkill M, Tompkin J, Zhen B, Waitz D, Norton L, et al. Are axillary recurrence and overall survival affected by axillary extranodal tumor extension in breast cancer? Implications for radiation therapy. J Clin Oncol 1995;13:47-53.
12. Pierce LJ, Oberman HA, Strawderman MH, Lichter AS. Microscopic extracapsular extension in the axilla: Is this an indication for axillary radiotherapy? Int J Radiat Oncol Biol Phys 1995;33:253-9.
13. Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, Cummings FJ, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotharapy with or without tamoxifen, without irradiation. J Clin Oncol 1999;17:1689-700.
14. Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 2000;18:2817-27.
15. Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001;50:735-42.
16. Ragaz J, Olivotto, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high risk breast cancer receiving adjuvant chemotherapy: 20- year results of British Columbia randomized trial.J Natl Cancer Inst 2005;97:116-26.
17. Bydder S, Spry N, Joseph DJ, Elsaleh H. Breast cancer survival advantage with radiotherapy. Lancet 2000;356:1270-1.
18. Whelan J, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiation therapy improve survival in breastcancer? A meta-analysis. J Clin Oncol 2000;18:1220-6.
19. Whelan T, Mackenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomed trial of regional irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002;94:1143-50.
20. Halverson KJ, Taylor ME, Perez CA, Garcia DM, Myerson R, Philpott G, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1993;26:593-9.